Delivery Order SPE2DX22D0010-SPE2D825FJD06
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Nucynta ER Tabs 200mg, a controlled-release pain management pharmaceutical. This non-set-aside, competitively awarded contract is valued at $6,062.41 with a firm fixed price structure and an ultimate completion date of September 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee, and the place of...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Nucynta ER Tabs 100mg, a prescription opioid pain management medication. This firm fixed-price delivery order, valued at $9,992.08, represents a competitive award with no set-aside designation and is scheduled for completion by July 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,101.84 for Nucynta ER Tabs 250mg, a pain management pharmaceutical. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed-price delivery order, valued at $4,442.48, is scheduled for completion by October 8, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's proven...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,268.26. This non-competitive delivery order represents a firm fixed-price transaction executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor agreement extending through December 2026. The place of performance is listed...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Nucynta ER Tabs 250mg, a controlled-release pain management pharmaceutical. This firm fixed-price delivery order, valued at $8,619.04 with an ultimate completion date of June 2, 2025, represents a non-competitive award executed under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office located in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Nucynta Tabs 75mg, a pain management pharmaceutical. This competitively awarded, non-set-aside contract carries a ceiling value of $12,375.14 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a contract ceiling value of $4,749.30. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The order is scheduled for ultimate completion on August 21, 2025, and will be fulfilled from AmerisourceBergen's corporate office...
- The U.S. Defense Department's Medical Supply Chain awarded a $11,313.88 delivery order to AmerisourceBergen Drug Corp on October 1, 2025, for the supply of Nucynta ER Tabs 100mg, a controlled-release pain management pharmaceutical. This competitive, firm fixed-price delivery order is scheduled for completion by October 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Nucynta ER 100 mg tablets (60-count) with a ceiling value of $1,400.62. This competitive, non-set-aside delivery order represents a firm fixed price contract with an ultimate completion date of August 27, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJD06Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Nucynta ER Tabs 100mg, a controlled-release pain management pharmaceutical. This competitively awarded, non-set-aside contract carries a ceiling value of $12,843.64 with firm fixed pricing and is scheduled for completion by September 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this delivery order, which falls under the company's larger Indefinite Delivery Contract (IDC) relationship with DLA Troop Support Medical. This delivery order leverages AmerisourceBergen Drug Corp's existing SPE2DX prime indefinite delivery vehicle with the Defense Logistics Agency, valued at $999,999,999.00 through December 2026. The SPE2DX contract functions as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply a broad range of medications, specialty pharmaceuticals, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's established federal contracting history and capability to deliver diverse pharmaceutical products through competitive procurement demonstrate its role as a critical vendor for Department of Defense medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 9/5/25 |